NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the E ...

Merck secures a positive CHMP opinion to expand Winrevair's PAH use, potentially broadening treatment to adult patients ...

GSK gets CHMP backing for Nucala in COPD and depemokimab in asthma, setting up possible Europe approvals in 2026 for IL-5 therapies.

The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, ...

Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...

Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...